服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-ANPT2;VEGFA mAbs [Zifibancimig Biosimilar] (MABL-5460) | MABL-5460 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-TNFSF13/CD256/APRIL mAbs [Zigakibart Biosimilar] (MABL-5461) | MABL-5461 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL6 mAbs [Ziltivekimab Biosimilar] (MABL-5462) | MABL-5462 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF4/CD134/OX40 mAbs [Vonlerolizumab Biosimilar] (MABL-5430) | MABL-5430 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E mAbs [Vonsetamig Biosimilar] (MABL-5431) | MABL-5431 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa;Kappa |
| Anti-IL2RA/CD25 mAbs [Vopikitug Biosimilar] (MABL-5432) | MABL-5432 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ICOS/CD278 mAbs [Vopratelimab Biosimilar] (MABL-5433) | MABL-5433 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFSF7/CD70/CD27LG mAbs [Vorsetuzumab Biosimilar] (MABL-5434) | MABL-5434 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FOLH1/GCPII/PSMA;CD3E mAbs [Voxalatamab Biosimilar] (MABL-5435) | MABL-5435 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Lambda |
| Anti-CTLA4/CD152;PDCD1/CD279/PD1 mAbs [Vudalimab Biosimilar] (MABL-5436) | MABL-5436 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-KDR/CD309/VEGFR2 mAbs [Vulinacimab Biosimilar] (MABL-5437) | MABL-5437 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL17A mAbs [Vunakizumab Biosimilar] (MABL-5438) | MABL-5438 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-STEAP1;CD3 mAbs [Xaluritamig Biosimilar] (MABL-5439) | MABL-5439 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Lambda |
| Anti-IL17A mAbs [Xeligekimab Biosimilar] (MABL-5440) | MABL-5440 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IGF1 and IGF2 mAbs [Xentuzumab Biosimilar] (MABL-5441) | MABL-5441 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-PDL1/CD274;TNFRSF9/CD137/4-1BB mAbs [Xirestomig Biosimilar] (MABL-5442) | MABL-5442 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Lambda;Lambda |
| Anti-BTLA/CD272 mAbs [Zadoprubart Biosimilar] (MABL-5443) | MABL-5443 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-MAPT mAbs [Zagotenemab Biosimilar] (MABL-5444) | MABL-5444 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CTLA4/CD152 mAbs [Zalifrelimab Biosimilar] (MABL-5445) | MABL-5445 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MASP3 mAbs [Zaltenibart Biosimilar] (MABL-5446) | MABL-5446 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn